RISK FACTORS FOR ISCHEMIC STROKE AND MODERN PREVENTION STRATEGY
Keywords:
risk factors, ischemic stroke, stroke preventionAbstract
Objective: To study the structure and frequency of risk factors (RFs) for ischemic stroke (IS) in a patient cohort.
Materials and Methods: Retrospective analysis of 120 medical records of patients with confirmed IS. Demographic data, medical history, and results of laboratory/instrumental examinations were evaluated. Statistical processing included descriptive methods, correlation analysis (χ², Student’s t-test).
Results: 18 risk factors were identified. The most common: arterial hypertension (AH) – 92.5%, dyslipidemia (DLP) – 78.3%, atrial fibrillation (AF) – 35.8%, type 2 diabetes mellitus (DM2) – 30.8%, smoking – 28.3%. ≥3 RFs were detected in 95% of patients. The combination of AH+DLP+AF was associated with the cardioembolic subtype of IS (p<0.01).
Conclusion: IS develops against a background of multifactorial pathology. Identification and correction of modifiable RFs (AH, DLP, DM2, smoking) are key to stroke prevention.
References
Балаболкин М.И., Клебанова Е.М., Креминская В.М. Сахарный диабет и инсульт: патогенетические аспекты и профилактика. Сахарный диабет. 2022;25(3):250–261.
Бойцов С.А., Баланова Ю.А., Концевая А.В., Деев А.Д., Дупляков Д.В., Ефанов А.Ю., и др. Распространенность факторов риска сердечно-сосудистых заболеваний в российской популяции (по данным исследования ЭССЕ-РФ). Российский кардиологический журнал. 2014;(11):4–12.
Воробьева О.В., Лукина Ю.Е., Вахнина Е.В., Сорокина Е.А., Дроздов А.И., Бойцов С.А. Ведение пациентов после ишемического инсульта в амбулаторных условиях (по данным регистра ЛИС-2). Неврология, нейропсихиатрия, психосоматика. 2022;14(4):13–19.
Скворцова В.И., Пирадов М.А., Стаховская Л.В., Бурд С.Г., Гулевская Т.С., Котов С.В., и др. Клинические рекомендации
«Транзиторная ишемическая атака». Неврологический журнал. 2021;26(4S):5–20.
Скворцова В.И., Пирадов М.А., Стаховская Л.В., Бурд С.Г., Гулевская Т.С., Котов С.В., и др. Национальные рекомендации по ведению пациентов с инсультом. Анналы неврологии. 2023;7(1S):4–112.
Суслина З.А., Пирадов М.А. Гиперкоагуляционные синдромы в неврологической практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(12):5–13.
Шальнова С.А., Баланова Ю.А., Концевая А.В., Имаева А.Э., Деев А.Д., Капустина А.В., и др. Артериальная гипертония и риск развития инсульта: данные исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2022;21(8S):5–12.
DT Hodzhieva, SS Pulatov, DK Hajdarova Vse o gemorragicheskom insul'te lic pozhilogo i starcheskogo vozrasta (sobstvennye nabljudenija) [All of hemorrhagic stroke in elderly persons (own observations)]. Nauka molodyh (Eruditio Juvenium)[Science of the young (Eruditio Juvenium)]. 2015. 87-96
Amarenco P, Kim JS, Labreuche J, et al. Time to Treatment With Ticagrelor and Aspirin in TIA or Minor Ischemic Stroke. N Engl J Med. 2023;388(1):21–31.
Khaydarova Dildora Kadirovna, Samadov Alibek Uktamovich. Current issues in the development of neuroprotective therapy in ischemic stroke. International Scientific Research Journal (WoS) 2021.
Feigin VL, Brainin M, Norrving B, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.
Dildora Khaydarova, Alibek Samadov. Optimization of neuroprotective therapy for ischemic stroke in the acute period. Журнал неврологии и нейрохирургических исследований. 2021.10.17.
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467.
Khaydarova Dildora Kadirovna, Xaydarov Nodirjon Kadirovich, Khodjyeva Dilbar Tadjiyevna. Clinical basis for the development of
neuroprotective therapy in acute ischemic stroke. International Journal of Health Sciences. 2022. Р 4177-4183
Mach F, Baigent C, Catapano AL, et al. 2023 ESC Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2023;44(37):3509–3556.
Ockene JK, Milliman R, Amick TL, et al. The Health Benefits of Cessation of Smoking. Circulation. 2021;143(8):833–836.
Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984–e1038.
Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2022;42(6):e170–e187.
World Health Organization. Noncommunicable diseases progress monitor 2020. Geneva: World Health Organization; 2020.
Williams B, Mancia G, Spiering W, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874–2071.
Wright JT, Williamson JD, Whelton PK, et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2021;325(18):1838–1849.
